Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH) - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Hepatology Année : 2020

Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH)

Résumé

Non-Alcoholic SteatoHepatitis (NASH) is considered as a pivotal stage in Non-Alcoholic Fatty Liver Disease (NAFLD) progression, as it paves the way for severe liver injuries such as fibrosis and cirrhosis. The etiology of human NASH is multi-factorial and identifying reliable molecular players and/or biomarkers has proven difficult. Together with the inappropriate consideration of risk factors revealed by epidemiological studies (altered glucose homeostasis, obesity, ethnicity, sex…), the limited availability of representative NASH cohorts with associated liver biopsies, the gold standard for NASH diagnosis, probably explains the poor overlap between published "omics"-defined NASH signatures.
Fichier principal
Vignette du fichier
Vandel_et_al_main_text_version auteurs HAL.pdf (2.28 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-02617094 , version 1 (25-05-2020)

Identifiants

Citer

Jimmy Vandel, Julie Dubois-Chevalier, Celine Gheeraert, Bruno Derudas, Violetta Raverdy, et al.. Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH). Hepatology, 2020, ⟨10.1002/HEP.31312⟩. ⟨inserm-02617094⟩
123 Consultations
71 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More